InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Shapiro Aron. Director active across 1 company, notably Kiora Pharmaceuticals INC. Aggregated, 1 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €10k. Activity tracked since 10 September 2024. The latest transaction was disclosed on 10 September 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条